Daratumumab for post-ASCT maintenance treatment of myeloma

Prashant Kapoor; Shaji Kumar

doi:10.1016/S1470-2045(21)00490-3

Daratumumab for post-ASCT maintenance treatment of myeloma

Hematology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1345-1347
Number of pages	3
Journal	The Lancet Oncology
Volume	22
Issue number	10
DOIs	https://doi.org/10.1016/S1470-2045(21)00490-3
State	Published - Oct 2021

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(21)00490-3

Cite this

@article{989741605ee643d69b1a89d142bfa09b,

title = "Daratumumab for post-ASCT maintenance treatment of myeloma",

author = "Prashant Kapoor and Shaji Kumar",

year = "2021",

month = oct,

doi = "10.1016/S1470-2045(21)00490-3",

language = "English (US)",

volume = "22",

pages = "1345--1347",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "10",

}

TY - JOUR

T1 - Daratumumab for post-ASCT maintenance treatment of myeloma

AU - Kapoor, Prashant

AU - Kumar, Shaji

PY - 2021/10

Y1 - 2021/10

UR - http://www.scopus.com/inward/record.url?scp=85115782885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115782885&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(21)00490-3

DO - 10.1016/S1470-2045(21)00490-3

M3 - Comment/debate

C2 - 34529932

AN - SCOPUS:85115782885

SN - 1470-2045

VL - 22

SP - 1345

EP - 1347

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 10

ER -

Daratumumab for post-ASCT maintenance treatment of myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this